RE:RE:Activist shareholder neededHoward's day job essentially pays him to participate in private placements, so we are not there yet.
At the point of revenue stabilization where the company can afford a full time leader (shall I say leaders) that would be the period where a CEO could be appointed, and then that person could also appoint a full time management team. If that doesn't happen then, there are enough large shareholders around that will make sure it does happen.
I don't see that being super far out. We have already waited 15 months since the signing of the Allergan AbbVie agreement and suspect somewhere in the next 3-6 months we will see it hit shelves, with evidence of launch potentially peaking through prior. Every expert I have consulted with has said that 18 months is the median benchmark with some going quicker, others going a little later.
I think the next pipeline to get signed will be anti aging and that looks to be significantly bigger than the 1067 lineup. So we are getting closer but not there yet in my view. Unless they sign a new agreement in the next few months and/or receive a milestone payment for the launch part of the Allergan AbbVie agreement, then a small private placement will be required to bridge the interim.
Good luck. Pretty cheap shares when we look forward, if one is willing to put faith in AbbVie/Allergan to come through, because when/if that starts with royalty on gross sales price, the hindsight would look intriguing.
All IFs and WHENs as we can all agree.